Soy protein diet significantly improves endothelial function and lipid parameters
- PMID: 11714128
- PMCID: PMC6655267
- DOI: 10.1002/clc.4960241105
Soy protein diet significantly improves endothelial function and lipid parameters
Abstract
Background: Replacement of animal protein with soy protein in the diet is associated with decreased cholesterol levels. However, the effects of soy protein diet on endothelial function are not well known.
Hypothesis: The aim of the study was to investigate the effects of soy protein diet on plasma lipids and endothelial function parameters assessed by two different methods.
Methods: Twenty hypercholesterolemic, nonsmoker male patients (age 50.1+/-11.8 years), with a normal body mass index, were included. After calculating their daily requirements, a diet with 25-30% of energy from fats. 10-12% from proteins, and the rest from carbohydrates was instituted. Sixty percent of the animal source proteins of the diet were substituted by soy. The anthropometric measures, lipid parameters, and endothelial functions of the subjects were assessed at baseline and 6 weeks after soy protein diet. Flow-mediated endothelium-dependent dilatation (EDD) and plasma thrombomodulin (TM) levels were evaluated as endothelial function parameters.
Results: After diet, plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and triglyceride levels decreased significantly (p <0.001, p < 0.001, p = 0.039, and p = 0.001, respectively). The mean plasma TM levels were also significantly reduced with diet (p = 0.004). Studies of the brachial artery indicated a borderline dilatation in baseline brachial artery diameter (p = 0.05), however the diameter at reactive hyperemia was significantly larger after diet (p<0.001), resulting in a significant improvement of EDD (p = 0.002).
Conclusion: Soy protein diet significantly improves plasma lipid profile in patients with hypercholesterolemia. Furthermore, the endothelial function, as judged by two different methods (EDD and plasma TM levels), also improves with soy protein diet.
Similar articles
-
Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women.Eur J Clin Nutr. 2003 Aug;57(8):889-94. doi: 10.1038/sj.ejcn.1601622. Eur J Clin Nutr. 2003. PMID: 12879082 Clinical Trial.
-
Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.Clin Invest Med. 1997 Jun;20(3):162-70. Clin Invest Med. 1997. PMID: 9189647 Clinical Trial.
-
Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects.Am J Clin Nutr. 2007 Apr;85(4):960-6. doi: 10.1093/ajcn/85.4.960. Am J Clin Nutr. 2007. PMID: 17413093 Clinical Trial.
-
Soy protein and cardiovascular disease: the impact of bioactive components in soy.Nutr Rev. 1998 Aug;56(8):231-5. doi: 10.1111/j.1753-4887.1998.tb01754.x. Nutr Rev. 1998. PMID: 9735676 Review.
-
Soy, soy phytoestrogens and cardiovascular disease.J Nutr. 2002 Mar;132(3):566S-569S. doi: 10.1093/jn/132.3.566S. J Nutr. 2002. PMID: 11880594 Review.
Cited by
-
Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men.Lipids. 2006 Mar;41(3):257-65. doi: 10.1007/s11745-006-5095-5. Lipids. 2006. PMID: 16711600 Clinical Trial.
-
Effects of plant protein and animal protein on lipid profile, body weight and body mass index on patients with hypercholesterolemia: a systematic review and meta-analysis.Acta Diabetol. 2020 Oct;57(10):1169-1180. doi: 10.1007/s00592-020-01534-4. Epub 2020 Apr 20. Acta Diabetol. 2020. PMID: 32314018
-
Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia.Food Funct. 2012 Oct;3(10):1051-8. doi: 10.1039/c2fo10284f. Epub 2012 Jun 27. Food Funct. 2012. PMID: 22739802 Free PMC article. Clinical Trial.
References
-
- Simons LA, Sullivan D Simons J Celermajer DS: Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on endothelial function in patients with severe primary hypercholesterolemia. Atherosclerosis 1998; 137: 197–203 - PubMed
-
- Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA: Estrogen improves endothelium‐dependent, flow‐mediated vasodilation in postmenopausal women. Arm Intent Med 1994; 121: 936–941 - PubMed
-
- Mancini GB, Henry GC, Macaya C, Q'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B: Angiotensin‐converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 94: 258–265 - PubMed
-
- Celermajer DS Sorensen KE Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992: 340: 1111–1115 - PubMed
-
- Takahashi H, Ito S, Hanano M, Wada K, Niwano H, Seki Y, Shibata A: Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von Willebrand factor and tissue‐type plasminogen activator. Am J Hematol 1992; 41: 32–39 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical